Subject
Physical and Theoretical Chemistry,Physics and Astronomy (miscellaneous),Condensed Matter Physics,Materials Science (miscellaneous),Biochemistry,Atomic and Molecular Physics, and Optics,Biophysics,Electronic, Optical and Magnetic Materials
Reference60 articles.
1. Evolution of androgen deprivation therapy (ADT) and its new emerging modalities in prostate cancer: an update for practicing urologists, clinicians and medical providers;Choi;Res. Rep. Urol.,2022
2. Development and prevalence of castration-resistant prostate cancer subtypes;Vellky;Neoplasia,2020
3. A review of the pathophysiological mechanisms underlying castration-resistant prostate cancer;Crowley;Res. Rep. Urol.,2021
4. Efficacy of PARP inhibitors as maintenance therapy for metastatic castration-resistant prostate cancer: a meta-analysis of randomized controlled trials;Niazi;Oncology,2021
5. Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer;Lavaud;Ther. Adv. Med. Oncol.,2020
Cited by
92 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Molecular structure, molecular docking, molecular dynamics simulation, and drug likeness evaluation of 3,7-dihydroxy-1,2-dimethoxyxanthone for its anticancer activity;Journal of Molecular Structure;2025-01
2. Advancing drug delivery and antimicrobial activity: Development and molecular docking analysis of quercetin-loaded pHEMA cryogel membranes;Journal of Molecular Structure;2025-01
3. Synthetic approaches for novel annulated pyrido[2,3-d]pyrimidines: Design, Structural Characterization, Fukui functions, DFT Calculations, Molecular docking and Anticancer efficiency;Journal of Molecular Structure;2024-12
4. Synthesis, structural characterization, fukui functions, DFT calculations, molecular docking and biological efficiency of some novel heterocyclic systems;Journal of Molecular Structure;2024-10
5. Novel Pyrrole Derivatives as Multi-Target Agents for the Treatment of Alzheimer’s Disease: Microwave-Assisted Synthesis, In Silico Studies and Biological Evaluation;Pharmaceuticals;2024-09-04